鱼疫苗市场概况、增长、趋势、分析、研究报告(2022-2030 年)

  • Report Code : TIPRE00020208
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 180
Buy Now

 

[研究报告] 2022 年鱼疫苗市场规模价值 3.5588 亿美元,预计到 2030 年将达到 6.1738 亿美元。预计 2022-2030 年期间的复合年增长率7.1%。

 

市场洞察和分析师观点:

随着政府大力发展水产养殖业以及对水产动物源性食品的需求不断增长,鱼类疫苗市场规模正在扩大。此外,市场上新型鱼类疫苗的开发预计将为鱼类疫苗市场创造充足的机会。近年来,由于研究和技术的进步,鱼类疫苗取得了长足的进步。传统疫苗存在局限性和缺点,这增加了对开发新型先进疫苗(如嵌合多表位疫苗)的需求。科学和技术的进步为水产疫苗的基础和应用研究领域开辟了新的途径。

 

增长动力和挑战:

 

由于对海鲜的需求量大,而每年野生鱼类的捕捞量却在减少,水产养殖业呈指数级增长。因此,各国政府正在采取措施改善和支持水产养殖业的发展。例如,2021 年 2 月,食品和农业研究基金会 ( FFAR ) 资助了 790,326 美元,用于创建一种疫苗的输送系统,该疫苗可帮助阻止罗非鱼湖病毒和其他疾病在水产养殖业中传播。

不健康的饮食习惯在发展中国家和发达国家日益受到关注,导致各种不良健康后果。因此,鱼类是健康成长和发育的饮食中非常值得推荐的,因为鱼类富含维生素、矿物质、脂质和蛋白质等常量营养素。此外,人们认为水产养殖是生产高质量蛋白质以实现人类可持续饮食的最有效方式。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

鱼疫苗市场:

Fish Vaccine Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

开发有效的粘膜疫苗并加强给药过程有望加速新型疫苗的开发,这将推动全球水产养殖业规范鱼类疫苗接种过程。因此,新型鱼类疫苗的开发可能会为市场增长创造重大机会。

鱼疫苗的使用必须得到使用地国家或地区相应主管部门的批准。在使用或交易之前,必须遵守相关主管部门制定的具体规则和建议。各国的授权和使用立法、要求和相关监管机构可能有所不同。欧盟的国家主管部门不能授权鱼疫苗。欧洲药品管理局为整个欧盟授权鱼疫苗。疫苗的生产成本很高,因为欧盟对疫苗制造商有严格的良好生产规范 ( GMP ) 指导方针。鱼疫苗的市场比其他动物物种的疫苗小,而且开发成本高于其他动物物种的疫苗。在美国,FDA 批准鱼疫苗。鱼疫苗的研发需要 10 年或更长时间,耗资 1000 万至 2000 万美元。因此,严格的政府法规阻碍了市场增长。

寄生虫、病毒和细菌引起的疾病爆发已经减缓了全球水产养殖业数十年的发展。除了危害人类健康外,新出现的疾病对水生动物也有重大影响。传统疫苗存在局限性和缺点,这增加了对开发新型先进疫苗(如嵌合多表位疫苗)的需求。科学技术的进步为水产疫苗的基础和应用研究领域开辟了新的途径。人们正在努力利用新技术、新方法和新策略创造更高质量、更有效的新型水产疫苗。

利用现有的生物信息学工具和免疫蛋白质组学和基因组学的现有知识,研究人员可以识别免疫细胞可以识别的潜在靶向表位。此外,随着全基因组测序等技术的成本不断下降,它为物种特异性疫苗开发开辟了道路。这可能会增加对开发新疫苗的投资。2021 年,中央咸水水产养殖研究所 ( ICAR ) 在印度推出了一种针对病毒性神经坏死 ( VNN ) 的重组疫苗。

因此,开发有效的粘膜疫苗并加强给药过程有望加速新型疫苗的开发,这将推动地中海国家的水产养殖业规范鱼类疫苗接种过程。因此,新型鱼类疫苗的开发可能会为市场增长创造巨大的机会

培育新鱼种,特别是海洋鱼,是水产养殖业的一个趋势。世界各地的农场越来越依赖疫苗来管理动物健康。具有广泛抗原多样性的新型病原体的出现也可能会降低传统疫苗的有效性。这促使疫苗研究人员研究新技术来研制有效的水产养殖疫苗。亚单位重组DNA/RNA 颗粒疫苗可能是使用现代疫苗技术研制出来的,该技术专注于特定的病原体成分​​。疫苗和疫苗学方面的最新进展使得寻找对抗鱼类病原体(如霉菌和寄生虫)的新型疫苗候选物成为可能。借助遗传学、免疫学和生物技术的新技术,可以快速研制和生产鱼疫苗。这些技术包括使用基因工程载体、重组疫苗和 DNA 疫苗。

DNA 疫苗技术可有效预防鱼类疾病。将构建体和/或转基因靶向抗原受体细胞是一种有希望提高 DNA 疫苗对抗其他病毒性疾病有效性的方法。分子组装可用于靶向DNA 疫苗中的树突状细胞 (DC) 和抗原呈递细胞 (APC),从而产生免疫反应。另一种策略是将 DNA 疫苗封装在特定载体中以增加转基因MHC表达。

新型疫苗(称为重组DNA 疫苗或新一代疫苗)的开发已广泛使用 R DNA 技术。重组 免疫原性蛋白疫苗或从携带目的基因的载体纯化的表位(在原核或真核表达系统中产生)、肽疫苗、通过特定基因操作产生的活疫苗以及携带免疫原性蛋白和 DNA 疫苗基因编码的微生物载体都是基于重组DNA 技术的疫苗类型重组 疫苗的优势在于可以紧密模拟自然感染,有助于在接受治疗的鱼中引发强大的免疫反应。

 

报告细分和范围:

 

鱼疫苗市场根据疫苗类型、应用、给药途径和物种进行划分。根据疫苗类型,鱼疫苗市场细分为灭活疫苗、活疫苗、亚单位疫苗、重组载体疫苗等。根据应用,鱼疫苗市场细分为细菌疫苗、病毒疫苗和寄生虫疫苗。根据给药途径,鱼疫苗市场分为注射、浸泡和口服。根据物种,鱼疫苗市场细分为鲑鱼、鳟鱼、罗非鱼等。根据地理位置,鱼疫苗市场细分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太其他地区)、中东和非洲(阿联酋沙特阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

节段分析:

 

根据疫苗类型,鱼疫苗市场分为灭活疫苗、活疫苗、亚单位疫苗、重组载体疫苗等。灭活疫苗在给水生动物注射后仍保持其免疫原性,并导致这些动物产生特异性抗性。灭活疫苗使用物理或化学方法灭活高毒性病原微生物。使用紫外线、高温加热、超声波和 G 射线是物理灭活技术的例子。化学灭活是使用化学物质分解有害细菌的核酸或蛋白质使其处于休眠状态的过程。与最广泛使用的灭活形式化学灭活相比,物理灭活困难、昂贵、受限且不稳定。灭活疫苗有助于对抗弧菌病、粘液杆菌病和弗朗西斯氏菌病等细菌性疾病的传播。灭活疫苗有多种优点,例如易于制备、储存和运输,以及高度安全和免疫原性的稳定性。

灭活鱼疫苗在各个国家/地区的供应预计将推动该领域的增长。例如,默克动物保健、默沙东动物保健、Pharmaq、Aquavac-vaccines 和 hipara 提供的灭活疫苗已获得美国 FDA 批准,可用于治疗各种鱼类疾病,如弧菌病、疖病、鲶鱼肠败血症 (ESC) 和巴氏杆菌病。这些疫苗在不同的地区/国家都有供应,例如美国、加拿大、日本、欧洲、澳大利亚、智利、越南、台湾、日本、巴西、印度尼西亚、挪威、英国、爱尔兰和冰岛。

根据应用,鱼疫苗市场分为细菌、病毒和寄生虫疫苗。2022 年,细菌疫苗占据了最大的市场份额,预计在 2022-2030 年期间将实现最高的复合年增长率。水质差、水生环境的有机负荷、鱼类处理和运输不当以及温度的剧烈变化经常导致鱼类细菌性疾病,因此推动了对能够帮助治疗鱼类细菌感染的疫苗的需求。

根据给药途径,鱼疫苗市场分为注射、浸泡和口服。2022 年,注射部分占据了最大的市场份额。预计浸泡部分将在 2022-2030 年期间实现最高复合年增长率。

根据物种,鱼疫苗市场分为鲑鱼、鳟鱼、罗非鱼和其他。2022 年,鲑鱼部分占据了最大的市场份额。预计其他部分在 2022-2030 年期间的复合年增长率最高。

 

区域分析:

 

根据地域,鱼疫苗市场分为北美、欧洲、亚太、中东和非洲以及南美和中美。北美是鱼疫苗市场增长的最大贡献者,亚太地区预计将成为未来几年增长最快的市场。北美市场的增长归因于美国水产养殖疫苗的增加。例如,根据世界银行的数据,美国生产了约 44.8 万公吨的水产养殖疫苗。根据同一来源,2021 年北美生产了约 560 万条鱼,其中约 470 万条在美国生产,约占该地区总产量的 83%。正在进行的与鱼类免疫系统相关的研究,用于开发更有效的疫苗,正在推动墨西哥市场的增长。例如,2022年12月,新墨西哥大学生物系萨利纳斯实验室的研究人员在虹鳟鱼的鼻腔中发现了一种免疫结构,这将有助于了解给鳟鱼注射的疫苗的有效性。

 

 

鱼疫苗市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响鱼疫苗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的鱼疫苗市场细分和地理位置。

Fish Vaccine Market
  • 获取鱼疫苗市场的区域特定数据

鱼疫苗市场报告范围

报告属性细节
2022 年市场规模3.5588亿美元
2030 年的市场规模6.1738亿美元
全球复合年增长率(2022 - 2030 年)7.1%
史料2020-2021
预测期2023-2030
涵盖的领域按疫苗类型
  • 灭活疫苗
  • 活疫苗
  • 亚单位疫苗
  • 重组载体疫苗
按应用
  • 细菌
  • 病毒性的
  • 寄生
按给药途径
  • 注射
  • 浸没
  • 口服
按物种
  • 三文鱼
  • 鳟鱼
  • 罗非鱼
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 硕腾公司
  • 默克公司
  • 希普拉公司
  • Phibro 动物保健公司
  • Vaxxinova国际有限公司
  • 京都美容研究所
  • 礼来动物保健公司
  • 日精研株式会社
  • KBNP公司

 

鱼疫苗市场参与者密度:了解其对业务动态的影响

鱼疫苗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在鱼疫苗市场运营的主要公司有:

  1. 硕腾公司
  2. 默克公司
  3. 希普拉公司
  4. Phibro 动物保健公司
  5. Vaxxinova国际有限公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Fish Vaccine Market

 

  • 了解鱼疫苗市场主要参与者概况

 

 

竞争格局和重点公司:

 

Zoetis Inc.、Merck & Co Inc.、Hipra SA、Phibro Animal Health Corp、Vaxxinova International BV、Kyoto Biken Laboratories、Elanco Animal Health Inc.、Nisseiken Co., Ltd.、KBNP Inc.、Choong Ang Vaccine Laboratories Co., Ltd. 和 INDIAN IMMUNOLOGICALS LTD. 是鱼疫苗市场中的几家知名企业。这些公司专注于扩大服务范围,以满足全球日益增长的消费者需求。它们的全球业务使它们能够服务于大量客户,从而扩大其市场份额。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the global fish vaccine market worldwide?

The growth of the global fish vaccine market is attributed to a few key factors, such as the government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products.

What is a fish vaccine?

Vaccination is a quick, efficient, and preventative method of disease prevention for fish. Through the administration of vaccines, a protective immune response is induced in an animal during vaccination.

Who are the major players in the fish vaccine market?

The fish vaccine market majorly consists of the players such as Zoetis Inc., Merck & Co Inc., Hipra SA, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories, Elanco Animal Health Inc., Nisseiken Co., Ltd., KBNP Inc., Choong Ang Vaccine Laboratories Co., Ltd., and INDIAN IMMUNOLOGICALS LTD.

Which segment is dominating the fish vaccine market?

The fish vaccine market is analyzed on the basis of vaccine type, application, route of administration, and species. Based on product, the market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on application, the market is classified as bacterial, viral, and parasitic. Based on route of administration, the market is segmented into injected, immersion, and oral. Based on species, the market is classified into salmon, trout, tilapia, and others

Which region is dominating the fish vaccine market?

North America region is dominating the fish vaccine market in terms of market share and Asia Pacific is anticipated to register the highest CAGR during 2022-2030.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Fish Vaccine Market

  1. Zoetis Inc
  2. Merck & Co Inc
  3. Hipra SA
  4. Phibro Animal Health Corp
  5. Vaxxinova International BV
  6. Kyoto Biken Laboratories
  7. Elanco Animal Health Inc
  8. Nisseiken Co., Ltd.
  9. KBNP Inc
  10. Choong Ang Vaccine Laboratories Co., Ltd.
  11. INDIAN IMMUNOLOGICALS LTD

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.